Kathryn Wunderle1, Kathleen M Hoeger, Erin Wasserman, Jeffrey J Bazarian. 1. (Ms Wunderle); Department of Obstetrics and Gynecology, (Dr Hoeger); Division of Epidemiology, Department of Public Health Sciences, (Ms Wasserman); Department of Emergency Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York (Dr Bazarian).
Abstract
OBJECTIVE: To determine whether menstrual cycle phase in women at the time of mild traumatic brain injury (mTBI) predicts 1-month outcomes. SETTING: Six emergency departments; 5 in Upstate New York, and 1 in Pennsylvania. PARTICIPANTS: One hundred forty-four female participants (age, 16-60) who presented to participating emergency departments within 4 hours of mTBI. DESIGN: Nested cohort study with neurologic and quality-of-life outcome assessment, 1 month after enrollment. Female subjects aged 16 to 60 enrolled in the parent cohort study, with 1-month neurological determination data available, were classified into menstrual cycle groups by serum progesterone concentration and self-reported contraceptive use. MAIN MEASURES: Rivermead Post Concussion Questionnaire and EuroQoL/EQ5D. RESULTS: Women injured during the luteal phase of their menstrual cycle, when progesterone concentration is high, had significantly lower EuroQoL General Health Ratings and Index Scores than women injured during the follicular phase of their cycle or women taking oral contraceptives. Multivariate analysis confirmed a significant independent effect of menstrual cycle phase on EuroQoL Index Score and the Rivermead Post Concussion Questionnaire Somatic Subscore. CONCLUSION: Menstrual cycle phase and progesterone concentration at the time of mTBI affect 1-month quality-of-life and neurologic outcomes. This association has important implications for treatment and prognosis after mTBI.
OBJECTIVE: To determine whether menstrual cycle phase in women at the time of mild traumatic brain injury (mTBI) predicts 1-month outcomes. SETTING: Six emergency departments; 5 in Upstate New York, and 1 in Pennsylvania. PARTICIPANTS: One hundred forty-four female participants (age, 16-60) who presented to participating emergency departments within 4 hours of mTBI. DESIGN: Nested cohort study with neurologic and quality-of-life outcome assessment, 1 month after enrollment. Female subjects aged 16 to 60 enrolled in the parent cohort study, with 1-month neurological determination data available, were classified into menstrual cycle groups by serum progesterone concentration and self-reported contraceptive use. MAIN MEASURES: Rivermead Post Concussion Questionnaire and EuroQoL/EQ5D. RESULTS:Women injured during the luteal phase of their menstrual cycle, when progesterone concentration is high, had significantly lower EuroQoL General Health Ratings and Index Scores than women injured during the follicular phase of their cycle or women taking oral contraceptives. Multivariate analysis confirmed a significant independent effect of menstrual cycle phase on EuroQoL Index Score and the Rivermead Post Concussion Questionnaire Somatic Subscore. CONCLUSION: Menstrual cycle phase and progesterone concentration at the time of mTBI affect 1-month quality-of-life and neurologic outcomes. This association has important implications for treatment and prognosis after mTBI.
Authors: Amy K Wagner; Emily H McCullough; Christian Niyonkuru; Haishin Ozawa; Tammy L Loucks; Julie A Dobos; Christopher A Brett; Martina Santarsieri; C Edward Dixon; Sarah L Berga; Anthony Fabio Journal: J Neurotrauma Date: 2011-06-01 Impact factor: 5.269
Authors: Daniel P Davis; Danielle J Douglas; Wendy Smith; Michael J Sise; Gary M Vilke; Troy L Holbrook; Frank Kennedy; A Brent Eastman; Thomas Velky; David B Hoyt Journal: J Neurotrauma Date: 2006-02 Impact factor: 5.269
Authors: Donna K Broshek; Tanya Kaushik; Jason R Freeman; David Erlanger; Frank Webbe; Jeffrey T Barth Journal: J Neurosurg Date: 2005-05 Impact factor: 5.115
Authors: David L Ripley; Cindy Harrison-Felix; Melissa Sendroy-Terrill; Christopher P Cusick; Amy Dannels-McClure; Clare Morey Journal: Arch Phys Med Rehabil Date: 2008-06 Impact factor: 3.966
Authors: Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit Journal: Nat Rev Neurol Date: 2015-03-17 Impact factor: 42.937
Authors: Sarah C Hellewell; Thomas Welton; Alan J Pearce; Jerome J Maller; Stuart M Grieve Journal: Brain Imaging Behav Date: 2021-06 Impact factor: 3.978
Authors: Doug King; Patria Hume; Cloe Cummins; Alan Pearce; Trevor Clark; Andrew Foskett; Matt Barnes Journal: Sports Med Date: 2019-10 Impact factor: 11.136
Authors: Emily L Dennis; Talin Babikian; Christopher C Giza; Paul M Thompson; Robert F Asarnow Journal: Childs Nerv Syst Date: 2017-09-06 Impact factor: 1.475
Authors: Rachel Sayko Adams; John D Corrigan; Beth A Mohr; Thomas V Williams; Mary Jo Larson Journal: J Neurotrauma Date: 2016-12-02 Impact factor: 5.269
Authors: David W Wright; Tamara R Espinoza; Lisa H Merck; Jonathan J Ratcliff; Anika Backster; Donald G Stein Journal: Acad Emerg Med Date: 2014-11-24 Impact factor: 3.451
Authors: Nefize Turan; Robert Allen-James Heider; Dobromira Zaharieva; Faiz U Ahmad; Daniel L Barrow; Gustavo Pradilla Journal: Transl Stroke Res Date: 2015-11-16 Impact factor: 6.829